Literature DB >> 26943964

Progesterone modulates pro-inflammatory cytokine expression profile after spinal cord injury: Implications for neuropathic pain.

María F Coronel1, María C Raggio1, Natalia S Adler1, Alejandro F De Nicola2, Florencia Labombarda2, Susana L González3.   

Abstract

Neuropathic pain is a frequent complication of spinal cord injury (SCI), still refractory to conventional treatment. Glial cell activation and cytokine production contribute to the pathology of central neuropathic syndromes. In this study we evaluated the effects of progesterone, a neuroactive steroid, on pain development and the spinal expression of IL-1β, its receptors (IL-1RI and IL-1RII) and antagonist (IL-1ra), IL-6 and TNFα, and NR1 subunit of NMDAR. Our results show that progesterone, by modulating the expression of pro-inflammatory cytokines and neuronal IL-1RI/NR1 colocalization, emerges as a promising agent to prevent chronic pain after SCI.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic pain; Glial activation; NMDA receptor; Neuroactive steroids; Pro-inflammatory cytokines; Spinal cord

Mesh:

Substances:

Year:  2016        PMID: 26943964     DOI: 10.1016/j.jneuroim.2016.01.011

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  14 in total

1.  Sex dimorphic regulation of osteoprogenitor progesterone in bone stromal cells.

Authors:  Alexander Kot; Zhendong A Zhong; Hongliang Zhang; Yu-An Evan Lay; Nancy E Lane; Wei Yao
Journal:  J Mol Endocrinol       Date:  2017-09-04       Impact factor: 5.098

Review 2.  Hormonal therapy in traumatic spinal cord injury.

Authors:  Parker E Ludwig; Arun A Patil; Andrea J Chamczuk; Devendra K Agrawal
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

Review 3.  Allopregnanolone and Progesterone in Experimental Neuropathic Pain: Former and New Insights with a Translational Perspective.

Authors:  Susana Laura González; Laurence Meyer; María Celeste Raggio; Omar Taleb; María Florencia Coronel; Christine Patte-Mensah; Ayikoe Guy Mensah-Nyagan
Journal:  Cell Mol Neurobiol       Date:  2018-09-05       Impact factor: 5.046

Review 4.  Sex differences in pain along the neuraxis.

Authors:  Peyton Presto; Mariacristina Mazzitelli; Riley Junell; Zach Griffin; Volker Neugebauer
Journal:  Neuropharmacology       Date:  2022-03-21       Impact factor: 5.273

Review 5.  Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship.

Authors:  Xin Sun; Zachary B Jones; Xiao-Ming Chen; Libing Zhou; Kwok-Fai So; Yi Ren
Journal:  J Neuroinflammation       Date:  2016-10-06       Impact factor: 8.322

6.  Progesterone and Allopregnanolone Rapidly Attenuate Estrogen-Associated Mechanical Allodynia in Rats with Persistent Temporomandibular Joint Inflammation.

Authors:  Rebecca S Hornung; William L Benton; Sirima Tongkhuya; Lynda Uphouse; Phillip R Kramer; Dayna Loyd Averitt
Journal:  Front Integr Neurosci       Date:  2020-05-08

7.  Progesterone Modulation of Pregnancy-Related Immune Responses.

Authors:  Nishel M Shah; Nesrina Imami; Mark R Johnson
Journal:  Front Immunol       Date:  2018-06-20       Impact factor: 7.561

Review 8.  Progesterone and Allopregnanolone Neuroprotective Effects in the Wobbler Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Alejandro F De Nicola; María Meyer; Laura Garay; Maria Sol Kruse; Michael Schumacher; Rachida Guennoun; Maria Claudia Gonzalez Deniselle
Journal:  Cell Mol Neurobiol       Date:  2021-06-17       Impact factor: 5.046

9.  Beyond reproduction: the role of progesterone in neuropathic pain after spinal cord injury.

Authors:  Susana Laura González; María Florencia Coronel
Journal:  Neural Regen Res       Date:  2016-08       Impact factor: 5.135

Review 10.  Nanofiber Scaffolds as Drug Delivery Systems to Bridge Spinal Cord Injury.

Authors:  Angela Faccendini; Barbara Vigani; Silvia Rossi; Giuseppina Sandri; Maria Cristina Bonferoni; Carla Marcella Caramella; Franca Ferrari
Journal:  Pharmaceuticals (Basel)       Date:  2017-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.